Abstract : Glutathione S-transferase GST is a major phase II drug-metabolizing enzyme. Several isoforms of human GST as well as different GST genetic polymorphisms are known, but limited data exists concerning the relationship between GST polymorphisms and GST activity using 1-chloro-2,4-dinitrobenzene in human liver. To resolve this query, we analyzed the genetic polymorphisms of four main GST isoforms GST mu 1 GSTM1 , GST theta 1 GSTT1 , GST alpha 1 GSTA1 , GST pi 1 GSTP1
Introduction
Glutathione S-transferase GST consists of multiple gene products that catalyze the conjugation of a wide variety of electrophilic drugs and chemicals. Cytosolic GST isozymes comprise seven different isoforms ; alpha A , mu M , omega O , pi P , sigma S , theta T and zeta Z 1 . The genetic polymorphisms of GSTM, GSTT, GSTA and GSTP influence the efficacy and safety of anti-cancer drugs, such as oxaliplatin, and affect cancer risk [2] [3] [4] .
Previous studies of the genetic polymorphisms associated with GST isoforms have established that the genetic differences in GSTM1, GSTT1, GSTA1 and GSTP1 decrease GST activity 1, 2 .
GSTM1 null gene deletion 5 , GSTT1 null gene deletion 6 , GSTA1 B 567T G 69C T 52G A 7 , and GSTP1 B exon 5, 313A G 8 are the major polymorphisms that affect GST activity. Zhou et al have reported that GSTM1 null formally known as GST-µ negative decreases GST activity when compared with GST-µ positive 9 . On the other hand, Arakawa et al have recently revealed that the GSTM1 null genotype does not alter GST activity 10 . GST plays an important role in the detoxification of many electrophilic compounds with reduced glutathione in the liver. Unfortunately, there is no reliable data on the relationship between GST variants and GST activity using 1-chloro-2,4-dinitrobenzene CDNB as a substrate in the human liver.
In the present study, we focused on four GST isoforms GSTM1, T1, A1 and P1 and compared the relationship between genetic variants of GST isoforms and GST activity using CDNB.
Materials and methods

Patients
Biopsy specimens of normal human liver noncancerous liver tissues were obtained from 18 Japanese hepatectomized patients 12 men, six women with non-viral liver carcinoma hepatocellular carcinoma, three patients ; intrahepatic cholangiocarcinoma, six patients ; metastatic liver cancer from colorectum and/or gastric cancer, nine patients at Showa University Hospital. The liver specimens were numbered anonymously. Written informed consent was obtained from all patients before the operation. This study was conducted in accordance with the Declaration of Helsinki and its amendments and was approved by Human Genome Ethics Committee, Showa University. Genomic DNA and total RNA were isolated from 18 individual liver samples but because insufficient cytosolic material was obtained in one specimen a total of 17 specimens were used.
Genotyping
Genomic DNA was extracted from liver tissue using a NucleoSpin Tissue Kit MachereyNagel GmbH & Co. KG, Düren, Germany . Genotyping of GSTM1 and GSTT1 null individuals was performed using multiplex polymerase chain reaction PCR 11 . GSTA1 B promoter region, 567T G 69C T 52G A was detected using the primers as described by Coles et al 7 . GSTP1 B exon 5, 313A G was detected using the primers 5 -tccccagtgactgtgtgttg-3 and 5 -gaagcccctttctttgttca-3 designed by the Primer3 output program http://bioinfo.ut.ee/primer3-0.4.0/ . GSTA1 B and GSTP1 B were identified by direct sequence methods as described by Toda et al 12 . PCR conditions and methods for the analysis of the GST genotype were performed as described by Kashiwabara et al 13 with some modification.
The PCR mixture contained 1.0 to 2. Eppendorf Japan Co., Ltd., Tokyo, Japan using the TaqMan Gene Expression Assay Life Technologies Japan Co., Ltd. for GSTM1 Hs01683722_gH , GSTT1 Hs00184475_m1 , GSTA1 Hs00275575_m1 and GSTP1 Hs02512067_s1 , and the TaqMan Gene Expression Master Mix Life Technologies Japan Co., Ltd. . Constitutively expressed human glyceraldehyde-3-phosphate dehydrogenase GAPDH Hs00266705_g1 was used as an internal control for normalization.
Cytosol Extraction
Liver tissues were homogenized with five volumes of 1.15 KCl solution using a PotterElvehjem homogenizer. The hepatic cell cytosol was isolated by differential centrifugation and the cytosolic samples were immediately stored at 80 . Protein concentration was estimated by the method of Lowry et al 15 using bovine serum albumin as a standard.
GST Activity Measurement and Chemicals 1-Chloro-2,4-dinitrobenzene CDNB was purchased from Sigma-Aldrich Co. Ltd. Tokyo, Japan . GST activity was measured by the method of Habig et al 16 using CDNB as a substrate. The final concentration of CDNB in a reaction mixture was 1 mM. A unit of GST activity was expressed as µmol/mg protein/min.
Statistical Analysis
Primary analysis was performed by Mann-Whitney U test for GST activity categorized into GST genotypes. P values were calculated for two-sided tests of primary analysis, with Bonferroni correction P 0.0083 considered statistically significant. As a secondary analysis, Spearman s rank correlation coefficient was used, and the relationship between mRNA expression and GST activity was evaluated. Data were analyzed with SPSS Statistics Version 23.0 IBM Japan, Co., Ltd., Tokyo, Japan .
Results and discussion
Initially, we analyzed the genetic variants associated with different GST isoforms. The genotype frequencies of GSTM1, GSTT1, GSTA1 and GSTP1 were determined and the frequencies of GSTM1 null, GSTT1 null, GSTA1 A/ B and GSTP1 A/ B genotypes were 77. 8 17 . These data suggest that GSTM1 null may be a useful biomarker in patients with non-viral liver carcinoma. Fig. 1 shows the relationships between GST activity and GST genotypes GSTM1 A , GSTT1 B , GSTA1 C , and GSTP1 D . GST activity is significantly decreased in the GSTM1 null genotype in comparison with GSTM1 positive Fig. 1A , P 0.0082 . This observation agrees with the findings of Seidegård et al 5 . The GSTT1 null, GSTA1 B, and GSTP1 B genotypes have been observed previously to affect GST activity [6] [7] [8] . We did not observe any statistically significant difference between GST activity and genotypes Fig. 1B , C, D , indicating that liver GST activity is affected mainly by GSTM1 variant. On the basis of these findings, we investigated whether the GSTM1 null genotype affects GST activity when the sample has the GSTA1 A/ A and GSTA1 A/ B or GSTP1 A/ A and GSTP1 A/ B genotypes. GSTA1 and GSTM1 are major GST isoforms and are apparently expressed in human liver 19, 20 . There were no statistically significant differences in GST activity between to 75 and the whiskers show the lowest and highest. GST activity values were analyzed by the Mann-Whitney U test P 0.01 ; n is the number of patients. 1-Chloro-2,4-dinitrobenzene was used to measure GST activity.
Although the patients in our study had no HBV infection, we concluded that GSTM1 null is a major genotype affecting GST activity when using CDNB as substrate in human liver. In addition, the GSTM1 null gene may be useful as a biomarker for the prediction of low GST activity.
Recently, Arakawa et al reported that the GSTM1 null genotype does not affect GST activity when using CDNB as a substrate 10 . Their results suggest that GSTA1 and GSTP1 may affect GST activity. We investigated and compared GST activity between GST genotypes including GSTA1 B and GSTP1 B because CDNB is a general substrate used to detect the total catalytic activity of GSTM1, GSTA1 and GSTP1 21 . However, we did not observe any differences in activity among the GST isoforms, which indicates that GSTM1 null genotype has a critical role in GST expression and in the maintenance of GST activity in human liver. The correlation between GST mRNA expression and GST activity is shown in Fig. 2 . The Spearman s rank correlation coefficients between GSTM1, GSTT1, GSTA1 and GSTP1 mRNA levels and GST activity exhibited r 0.626 P 0.007 , r 0.187 P 0.473 , r 0.167 P 0.523 , and r 0.172 P 0.510 in GSTM1, GSTT1, GSTA1 and GSTP1, respectively. Thus, we observed a significant correlation between GSTM1 mRNA expression and GST activity.
GSTM1 and GSTA1 mRNAs are expressed predominantly in the liver 22 . Therefore, it is possible that GSTA1 affects GST activity but we did not observe a decrease in GST activity in the GSTA1 A/ B genotype Fig. 1C , E . In this respect, Arakawa et al showed that GST activity is apparently maintained with GSTM1 null genotype when compared with GSTM1 positive genotype 10 . In addition, the GSTA1 B genotype has been shown to result in decreased protein expression and GST activity because of decreased activation of the proximal promoters of GSTA1 in HepG2 cells 7, 23, 24 . The aryl hydrocarbon receptor AhR regulates the expression of GSTA1 and GSTA2 mRNAs 25, 26 , therefore we investigated the relationship between the expression of AhR mRNA and GSTA1 mRNA. There is no significant difference between the expression levels of these genes r 0.195, data not shown , which suggests that AhR does not regulate GSTA1 mRNA expression.
Moscow et al and Nishimura and Naito have reported that GSTP1 mRNA is expressed at a low level in the liver in comparison with other tissues 22, 27 . In the present study, we observed that GSTP1 mRNA is expressed in human liver. GSTP1 mRNA expression is significantly induced by the presence of the GSTP1 Val 105 variant allele 28 . Therefore, it is apparent that GSTP1 genotypes affect GST activity. Although it has been reported that the GSTA1 B as well as the GSTP1 B genotypes could significantly affect GST activity 8, 24 , we observed that GSTA1 B has little effect on GST activity, indicating that GSTM1 genotypes may be largely responsible for GST activity.
In conclusion, we investigated the simultaneous analysis of GST genotypes including GSTM1, GSTT1, GSTA1 and GSTP1 and liver GST activity in Japanese patients with non-viral liver tumors. Although we obtained a limited number of patient specimens, we identified that the GSTM1 positive or GSTM1 null genotypes are responsible for GST activity using CDNB as a substrate. A single GST substrate, CDNB, was used in this study because this compound is a common substrate for measurement and evaluation of the enzymatic activities of GSTM1, GSTA1 and GSTP1 in human liver 21 . A number of factors are associated with the regulation of GST activity and inter-individual differences have been reported. The results of this study will facilitate the prediction of the efficacy and safety of GST-mediated drug metabolism including platinum-containing anti-cancer agents such as cisplatin and oxaliplatin. This study indicated that genetic polymorphisms of the GST gene can act as a biomarker, however studies with a greater number of participants are necessary to clarify the relationship between the genotype of GST isoforms and GST activity. P 0.01 . The correlation between GSTM1 mRNA level and GST activity was significant P 0.007 . No statistically significant difference was observed in GSTT1, GSTA1 and GSTP1 mRNAs with GST activity. GAPDH, glyceraldehyde-3-phosphate dehydrogenase ; GST, glutathione S-transferase ; r, rank correlation coefficient.
